ArticleBMC neurology2024
Genetic association between serum 25-hydroxyvitamin D levels and functional outcome after ischemic stroke.
Article in BMC neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Low Vitamin D Status and Post-Stroke Depression, Falls, and Functional Recovery in Older Adults with Nonvalvular Atrial Fibrillation-Associated Ischemic Stroke.Clinical interventions in aging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundPrevious observational studies suggest that serum 25-hydroxyvitamin D [25(OH)D] levels may associate with functional outcome after ischemic stroke. However, the causal relationship is not yet defined. Consequently, this study employed two-sample Mendelian Randomization (MR) to elucidate the causal association between serum 25(OH)D levels and functional outcome after ischemic stroke.
methodsThe genome-wide association study (GWAS) for serum 25(OH)D levels included 417,580 patients of European descent. The GWAS for functional outcome after ischemic stroke is from Genetics of Ischemic Stroke Functional Outcome meta-analysis. Post-stroke outcomes were evaluated using two sets of binary categorical variables (0-2 vs. 3-6 and 0-1 vs. 2-6), and also as ordered modified Rankin Scale (mRS) variables at 3 months. Two-sample MR was used to assess whether the exposure causally affects the outcome. Inverse Variance Weighted (IVW) was the primary method for our MR analysis, which was further supported by sensitivity analyses to ensure the robustness of the results.
resultsThe primary analysis using IVW method indicated no significant casual association between serum 25(OH)D levels and mRS (0-1) vs. mRS (2-6) at 3 months (OR = 0.914, 95% CI: 0.587-1.422, P = 0.69), mRS (0-2) vs. mRS (3-6) at 3 months (OR = 0.699, 95% CI: 0.477-1.025, P = 0.07), and mRS at 3 months (OR = 1.202, 95% CI: 0.875-1.650, P = 0.26). Additionally, after adjusting for stroke severity, the IVW analysis also showed no significant association between serum 25(OH)D levels and mRS (0-1) vs. mRS (2-6) at 3 months (OR = 0.93, 95% CI: 0.55-1.56, P = 0.78), mRS (0-2) vs. mRS (3-6) at 3 months (OR = 0.73, 95% CI: 0.47-1.13, P = 0.16), and mRS at 3 months (OR = 1.09, 95% CI: 0.77-1.54, P = 0.62). The results of the sensitivity analysis suggest that our findings are robust.
conclusionOur MR study offers no genetic evidence supporting the effects of serum 25(OH)D levels on functional outcomes after ischemic stroke. The associations observed in previous observational studies may be attributed to residual confounding factors and reverse causality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.